ZVRA FY 2017 Earnings — Zevra Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ZVRAZevra Therapeutics, Inc.

$559M

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$336,000

Operating Income

-$33M

Net Income

-$43M

EPS (Diluted)

$-47.37

Cash Flow

Operating Cash Flow

-$33M

Free Cash Flow

-$33M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$52M

Total Liabilities

$110M

Stockholders' Equity

-$58M

Cash & Equivalents

$11M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$336,000	-$175,000	-92.0%
Operating Income	-$33M	-$37M	+11.0%
Net Income	-$43M	-$17M	-162.7%